Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Yukinaga Kishikawa"'
Autor:
Aoi Noda, Taku Obara, Kazuki Takada, Yukinaga Kishikawa, Shinya Abe, Shoko Yoshimachi, Nariyasu Mano, Yutaka Imai, Teruaki Goto
Publikováno v:
Clinical and Experimental Hypertension, Vol 42, Iss 4, Pp 322-327 (2020)
Objective: To clarify changes in community pharmacists’ knowledge, attitudes, and practice regarding the management of hypertension before and after attending educational interventions based on their self-report on a questionnaire survey. Method: W
Externí odkaz:
https://doaj.org/article/da34fabb4597473cadceabc25852caed
Autor:
Daisuke Tsutsumi, Tatsuya Hayama, Katsuhiro Miura, Akihiro Uchiike, Shinya Tsuboi, Susumu Otsuka, Yoshihiro Hatta, Yukinaga Kishikawa
Publikováno v:
International Journal of Clinical Pharmacy. 44:366-373
Background Infusion-related reactions (IRRs) during rituximab administration are occasionally severe and remain problematic in oncology practice. Aim To establish a safer, risk-stratified rituximab protocol for patients with B-cell lymphoma. Method W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a542f91a29bbe2ee3dd99157ba9f6dd5
https://doi.org/10.1007/s11096-021-01348-6
https://doi.org/10.1007/s11096-021-01348-6
Autor:
Yasuhito Nobushi, Taira Wada, Yuzuki Koike, Hikari Kaneko, Shigeki Shimba, Taketo Uchiyama, Yukinaga Kishikawa
Publikováno v:
Biologicalpharmaceutical bulletin. 45(10)
Obesity is currently the most common cause of metabolic diseases including type 2 diabetes and hyperlipidemia. Obesity results from excess lipid accumulation in adipose tissue. Several studies have investigated the inhibitory effects of natural plant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f31ea3aa75703583b8f9902c3acd121
https://pubmed.ncbi.nlm.nih.gov/36184503
https://pubmed.ncbi.nlm.nih.gov/36184503
Autor:
Yoshihiro Hatta, Yukinaga Kishikawa, Tatsuya Hayama, Akihiro Uchiike, Susumu Otsuka, Katsuhiro Miura, Daisuke Tsutsumi, Shinya Tsuboi
Background Rituximab is widely used as a key component of immunochemotherapy to treat B-cell non-Hodgkin lymphoma (B-NHL). However, infusion-related reactions (IRRs) during drug administration are occasionally severe or even life-threatening and thus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::507f9aab4cd1e10f604761e397063f67
https://doi.org/10.21203/rs.3.rs-909741/v1
https://doi.org/10.21203/rs.3.rs-909741/v1
Autor:
Shoko Yoshimachi, Teruaki Goto, Taku Obara, Kazuki Takada, Yutaka Imai, Aoi Noda, Nariyasu Mano, Yukinaga Kishikawa, Shinya Abe
Publikováno v:
Clinical and Experimental Hypertension. 42:322-327
Objective: To clarify changes in community pharmacists' knowledge, attitudes, and practice regarding the management of hypertension before and after attending educational interventions based on their self-report on a questionnaire survey.Method: We c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e68761c2714b887bd87c8fa87107e92a
https://doi.org/10.1080/10641963.2019.1652634
https://doi.org/10.1080/10641963.2019.1652634
Autor:
Fumiyoshi Ojima, Shigeki Andou, Yukinaga Kishikawa, Fumiaki Ishizawa, Jo Satoh, Miori Hase, Junji Sakurai, Tomoko Takahashi, Shinsuke Satoh
Publikováno v:
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 140(7)
Studies on the drug saxagliptin (marketed in Japan since 2013) suggest favorable efficacy in hemodialysis patients, but included small sample sizes. Noting that some hemodialysis patients at our medical institution had been switched to saxagliptin 2.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fa3f9b5468c4d85362050ce3e1615f2
https://pubmed.ncbi.nlm.nih.gov/32612059
https://pubmed.ncbi.nlm.nih.gov/32612059
Publikováno v:
Biologicalpharmaceutical bulletin. 43(3)
Obesity elevates the risk of cardiovascular disease and has been strongly associated with increases in the incidence of many metabolic diseases. Therefore, prevention of obesity leads to the prevention of metabolic diseases. In light of this, substan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5738b20556a2b511031664846c82883
https://pubmed.ncbi.nlm.nih.gov/32115509
https://pubmed.ncbi.nlm.nih.gov/32115509
Autor:
Yoshihiro Hatta, Takashi Yamauchi, Yukinaga Kishikawa, Shinya Tsuboi, Daisuke Tsutsumi, Susumu Ootsuka, Katsuhiro Miura, Akihiro Uchiike, Isamu Odagiri, Tatsuya Hayama
Publikováno v:
Blood. 138:1934-1934
Introduction: Rituximab is widely used as the standard treatment for most types of B-cell non-Hodgkin lymphomas (B-NHL). However, infusion-related reactions (IRRs), such as fever, chills, nausea, rashes, rigors, or hypotension, are a significant burd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7fc9a219d674ffe43994fd221e1b3215
https://doi.org/10.1182/blood-2021-145088
https://doi.org/10.1182/blood-2021-145088
Autor:
Keiichi Tabata, Yukinaga Kishikawa, Eiji Kose, Megumi Izumisawa, Yoshihisa Ito, Satoru Asami, Takashi Suzuki, Norio Inokuchi, Harumi Hata, Shin-ichi Ono, Hiroyuki Hayashi, Kumiko Ishige, Yasuhiro Kosuge, Hiroko Kobayashi
Publikováno v:
YAKUGAKU ZASSHI. 137:1419-1423
It has been recommended that active learning methods, such as team-based learning (TBL) and problem-based learning (PBL), be introduced into university classes by the Central Council for Education. As such, for the past 3 years, we have implemented T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1f91be28ac25abe52c69e35608158d4
https://doi.org/10.1248/yakushi.17-00094
https://doi.org/10.1248/yakushi.17-00094
Autor:
Tetsuya Harigaya, Yukinaga Kishikawa, Keiichi Matsuzaki, Ken Yasukawa, Yasuhito Nobushi, Shigetoshi Tsutsumi, Yurika Tsuda
Publikováno v:
Japanese Journal of Complementary and Alternative Medicine. 14:77-82
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5b88b744b0b9c77ed98c80e243ef2de
https://doi.org/10.1625/jcam.14.77
https://doi.org/10.1625/jcam.14.77